Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Challenges in Treating Incarcerated Patients With Cancer.

Turaka A.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):1083. doi: 10.1016/j.ijrobp.2016.01.045. No abstract available.

PMID:
27302518
2.

Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.

Hall MJ, Innocent J, Rybak C, Veloski C, Scott WJ, Wu H, Ridge JA, Hoffman JP, Borghaei H, Turaka A, Daly MB.

Appl Clin Genet. 2015 Feb 17;8:69-73. doi: 10.2147/TACG.S72223. eCollection 2015.

3.

Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.

Mehta MP, Wang D, Wang F, Kleinberg L, Brade A, Robins HI, Turaka A, Leahy T, Medina D, Xiong H, Mostafa NM, Dunbar M, Zhu M, Qian J, Holen K, Giranda V, Curran WJ.

J Neurooncol. 2015 Apr;122(2):409-17. doi: 10.1007/s11060-015-1733-1. Epub 2015 Feb 15.

PMID:
25682091
4.

Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy.

Shaikh T, Turaka A.

Cancer Treat Rev. 2014 Dec;40(10):1215-20. doi: 10.1016/j.ctrv.2014.09.003. Epub 2014 Sep 16. Review.

PMID:
25261888
5.

Absolute lymphocyte count: a novel prognostic factor for merkel cell carcinoma.

Johnson ME, Turaka A, Zhu F, Galloway T, Farma J, Perlis C.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S10-1. doi: 10.1016/j.prro.2013.01.036. Epub 2013 Mar 25. No abstract available.

PMID:
24674471
6.

Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.

Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A.

J Am Acad Dermatol. 2014 Jun;70(6):1028-35. doi: 10.1016/j.jaad.2014.01.890. Epub 2014 Mar 22.

PMID:
24666998
7.

Nasopharyngeal Hodgkin lymphoma.

Johnson ME, Robu VG, Turaka A.

J Clin Oncol. 2014 Apr 10;32(11):e40-1. doi: 10.1200/JCO.2012.48.6183. Epub 2014 Jan 21. No abstract available.

8.

Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.

Aggarwal C, Li L, Borghaei H, Mehra R, Somaiah N, Turaka A, Langer CJ, Simon GR.

Cancer Control. 2014 Jan;21(1):57-62.

9.

A better prognosis for Merkel cell carcinoma of unknown primary origin.

Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM.

Am J Surg. 2013 Nov;206(5):752-7. doi: 10.1016/j.amjsurg.2013.02.005. Epub 2013 Jul 5.

PMID:
23835211
10.

In reply to Cheung.

Turaka A, Buyyounouski MK, Horwitz EM, Movsas B.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):6-7. doi: 10.1016/j.ijrobp.2013.01.013. No abstract available.

PMID:
23582244
11.

Lacrimal gland lymphoma: Role of radiation therapy.

Townsend N, Turaka A, Smith MR.

Oman J Ophthalmol. 2012 Jan;5(1):37-41. doi: 10.4103/0974-620X.94765.

12.

Radiation therapy for pituitary metastasis: report of four cases.

Turaka A, Parsons RB, Buyyounouski MK.

Tumori. 2012 Jan-Feb;98(1):e1-6. doi: 10.1700/1053.11520.

PMID:
22495726
13.

Target repositional accuracy and PTV margin verification using three-dimensional cone-beam computed tomography (CBCT) in stereotactic body radiotherapy (SBRT) of lung cancers.

Wang L, Feigenberg S, Fan J, Jin L, Turaka A, Chen L, Ma CM.

J Appl Clin Med Phys. 2012 Mar 8;13(2):3708. doi: 10.1120/jacmp.v13i2.3708.

PMID:
22402387
14.

Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results.

Turaka A, Buyyounouski MK, Hanlon AL, Horwitz EM, Greenberg RE, Movsas B.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e433-9. doi: 10.1016/j.ijrobp.2011.05.037. Epub 2011 Oct 8.

PMID:
21985947
15.

A rare complication of a CT-guided biopsy.

Turaka A, Parsons RB.

J Thorac Oncol. 2011 Aug;6(8):1438. doi: 10.1097/JTO.0b013e318220907e. No abstract available.

16.

Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.

Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ.

Am J Clin Oncol. 2010 Dec;33(6):599-603. doi: 10.1097/COC.0b013e3181c4c3cc.

PMID:
21063195
17.

Surgery in the multimodality treatment of sinonasal malignancies.

Lango MN, Topham NS, Perlis CS, Flieder DB, Weaver MW, Turaka A, Patel SA, Ridge JA.

Curr Probl Cancer. 2010 Sep-Oct;34(5):304-21. doi: 10.1016/j.currproblcancer.2010.07.001. Review. No abstract available.

PMID:
20851263
18.

Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.

Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ.

Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):65-70. doi: 10.1016/j.ijrobp.2009.10.034. Epub 2010 Apr 10.

19.

Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.

Turaka A, Freedman GM, Li T, Anderson PR, Swaby R, Nicolaou N, Goldstein L, Sigurdson ER, Bleicher RJ.

J Surg Oncol. 2009 Jul 1;100(1):25-31. doi: 10.1002/jso.21284.

20.

Palliative radiotherapy in paediatric malignancies.

Bhasker S, Bajpai V, Turaka A.

Singapore Med J. 2008 Dec;49(12):998-1001.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk